[Changes in the urinary excretion of VMA (vanilmandelic acid) in patients with hyperthyroidism treated chronically with guanethidine]. 1969

I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005260 Female Females
D006145 Guanethidine An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,Guanethidine Monosulfate,Guanethidine Sulfate,Guanethidine Sulfate (1:1),Guanethidine Sulfate (1:2),Guanethidine Sulfate (2:1),Guanethidine Sulfate (2:1), 14C-Labeled,Ismelin,Isobarin,Octadine,Oktadin,Monosulfate, Guanethidine,Sulfate, Guanethidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014642 Vanilmandelic Acid A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE. Methoxyhydroxymandelic Acid,4-Hydroxy-3-Methoxymandelic Acid,Vanillylmandelic Acid,4 Hydroxy 3 Methoxymandelic Acid,Acid, 4-Hydroxy-3-Methoxymandelic,Acid, Methoxyhydroxymandelic,Acid, Vanillylmandelic,Acid, Vanilmandelic

Related Publications

I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
January 1965, Annales medicinae internae Fenniae,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
August 1966, American journal of ophthalmology,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
January 1965, Annales medicinae internae Fenniae,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
May 1975, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
September 1982, Klinika oczna,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
June 1963, The Journal of pediatrics,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
August 1971, Polskie Archiwum Medycyny Wewnetrznej,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
June 1968, Archives of disease in childhood,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
May 1979, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques,
I Portioli, and G Bufano, and F Rocchi, and S Tagliavini, and G Botti
October 1971, Nihon Shonika Gakkai zasshi. Acta paediatrica Japonica,
Copied contents to your clipboard!